Abstract
ObjectivesCurrently there are no guidelines regarding the possibility and the timing of the discontinuation of biological therapy in patients with sustained remission. The authors’ aim was to assess the disease...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
